Inventor · disambiguated record
Yelena Kovtun
Also filed as: KOVTUN YELENA · KOVTUN YELENA V
16 granted patents·5 pending applications·172 citations·filing 1999–2022
94Inventor score
Top patents by PatentIndex Score
21 records- 0197US8236319B2Cross-linkers and their usesCHARI RAVI V J·Filed 2009·Granted Aug 7, 2012·60 cites·15 claims
- 0294US10875925B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2020·Granted Dec 29, 2020·3 cites·12 claims
- 0394US10077313B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2016·Granted Sep 18, 2018·12 cites·28 claims
- 0494US9061995B2Cross-linkers and their usesIMMUNOGEN INC·Filed 2013·Granted Jun 23, 2015·17 cites·33 claims
- 0594US8613930B2Cross-linkers and their usesCHARI RAVI V J·Filed 2012·Granted Dec 24, 2013·17 cites·26 claims
- 0693US11332535B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2020·Granted May 17, 2022·2 cites·14 claims
- 0793US10919969B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2017·Granted Feb 16, 2021·4 cites·4 claims
- 0893US9498541B2Cross-linkers and their usesIMMUNOGEN INC·Filed 2015·Granted Nov 22, 2016·10 cites·21 claims
- 0990US9150649B2Potent conjugates and hydrophilic linkersSINGH RAJEEVA·Filed 2009·Granted Oct 6, 2015·13 cites·20 claims
- 1090US8137669B2Elimination of heterogeneous or mixed cell population in tumorsGOLDMAKHER VIKTOR S·Filed 2008·Granted Mar 20, 2012·7 cites·5 claims
- 1188US10442865B2Methods of use of anti-CD123 antibodies and antigen-binding fragments thereofIMMUNOGEN INC·Filed 2018·Granted Oct 15, 2019·4 cites·16 claims
- 1288US8388960B2Elimination of heterogeneous or mixed cell population in tumorsGOLDMAKHER VIKTOR S·Filed 2011·Granted Mar 5, 2013·7 cites·3 claims
- 1384US10494431B2Cross-linkers and their usesIMMUNOGEN INC·Filed 2018·Granted Dec 3, 2019·2 cites·8 claims
- 1481US11897961B2Anti-CD123 antibodies and conjugates and derivatives thereofIMMUNOGEN INC·Filed 2022·Granted Feb 13, 2024·0 cites·11 claims
- 1576US11046762B2Cross-linkers and their usesIMMUNOGEN INC·Filed 2019·Granted Jun 29, 2021·0 cites·7 claims
- 1664US2006233814A1Elimination of heterogeneous or mixed cell population in tumorsIMMUNOGEN INC·Filed 2006·Application pending·0 cites
- 1762US2017157264A1Cross-linkers and their usesIMMUNOGEN INC·Filed 2016·Application pending·0 cites
- 1859US6613959B1Transgenic plants expressing a MAPKKK protein kinase domainGEN HOSPITAL CORP·Filed 1999·Granted Sep 2, 2003·14 cites·9 claims
- 1953US2004181829A1Transgenic plants expressing a MAPKKK protein kinase domainFiled 2003·Application pending·0 cites
- 2052US2016114052A1Potent conjugates and hydrophilic linkersIMMUNOGEN INC·Filed 2015·Application pending·0 cites
- 2139US2017080102A1Methods for characterizing and treating acute myeloid leukemiaIMMUNOGEN INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →